Mrs. Dawn S. Eberhardt is a pharmacist who is specialized in Pharmacotherapy in Pineville, Louisiana. Patients can reach her at 2495 Shreveport Hwy, Pineville or contact her on 318-473-0010. Active license number of Mrs. Dawn S. Eberhardt is 17237 for Pharmacotherapy in Louisiana. Mrs. Dawn S. Eberhardt is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Mrs. Dawn S. Eberhardt speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mrs. Dawn S. Eberhardt are as mentioned below.
NPI Number:
1447376280
NPI Enumeration Date:
22 Mar, 2007
NPI Last Update On:
13 Sep, 2013
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Dawn S. Eberhardt are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
17237
Louisiana
Primary
Pharmacotherapy
12283
Wisconsin
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2495 Shreveport Hwy, Pineville, Louisiana
Zip:
71360-4044
Phone Number:
--
Fax Number:
--
Patients can reach Mrs. Dawn S. Eberhardt at 2495 Shreveport Hwy, Pineville, Louisiana or can call on phone at 318-473-0010.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.